agenebio.com
Events - AgeneBio | Developing Innovative Therapeutics that Preserve and Restore Brain Function : AgeneBio | Developing Innovative Therapeutics that Preserve and Restore Brain Function
http://www.agenebio.com/about-us/events
AGB101 for Amnestic Mild Cognitive Impairment (aMCI). About aMCI and Alzheimer’s Dementia. Novel GABA(A) α5 Discovery Program. AMCI and Alzheimer’s Dementia. News & Events. Join the AgeneBio team at these upcoming industry events. February 23, 2016. Neuroscience BioPartnering & Investment Forum. February 2, 2016. BIO CEO & Investor Conference. December 3, 2015. Future of Innovation in Medicine Conference: Incentives for New Medical Treatments and Global Health. November 19, 2015. November 7, 2015. Clinic...
jpreventionalzheimer.com
Current issue • The Journal of Prevention of Alzheimer's Disease
http://www.jpreventionalzheimer.com/current-issue.html
Subscription / Log in. Ahead of print articles. ALZHEIMER’S ASSOCIATION: INITIATIVES and PUBLIC HEALTH PERSPECTIVE. HM Snyder, M.C. Carrillo. HM Snyder ; M.C. Carrillo (2016): Alzheimer’s Association: Initiatives and Public Health Perspective. The Journal of Prevention of Alzheimer’s Disease (JPAD). http:/ dx.doi.org/10.14283/jpad.2016.111. AF Cicero, M. Bove, A. Colletti, M. Rizzo, F. Fogacci, M. Giovannini, C. Borghi. C Vassalle ; L. Sabatino ; A. Pingitore ; K. Chatzianagnostou ; F. Ma...R Sperling, J...
jpreventionalzheimer.com
Editorial board • The Journal of Prevention of Alzheimer's Disease
http://www.jpreventionalzheimer.com/editorial-board.html
Subscription / Log in. Jacques Touchon (Montpellier, France). Bruno Vellas (Toulouse, France). Paul Aisen (San Diego, USA). Sections and Associate Editors. Methodological Aspects of Preventive Trials: Sandrine Andrieu (Toulouse, France). Operational Aspects of Preventive Trials: Bruno Vellas (Toulouse, France). Health Economic and Finances Aspects: Ara Khachaturian (Washington, USA). Health Policy, Regulations: Zaven Khachaturian (Potomac, USA). Bioinformatics Analytics: Ron Thomas (San Diego, USA).
jpreventionalzheimer.com
Past issues • The Journal of Prevention of Alzheimer's Disease
http://www.jpreventionalzheimer.com/past-issue.html
Subscription / Log in. TOP 5 downloaded articles. Check out top downloaded articles. CTAD: SYMPOSIA, ORAL COMMUNICATIONS, POSTERS. J Prev Alz Dis 2015;2(4):269-396. Download PDF (3.03 Mo). ENDPOINTS FOR PRE-DEMENTIA AD TRIALS: A REPORT FROM THE EU/US/CTAD TASK FORCE. B Vellas, R. Bateman, K. Blennow , G. Frisoni , K. Johnson, R. Katz , J. Langbaum, D. Marson , R. Sperling, A. Wessels, S. Salloway, R. Doody, P. Aisen, Task Force Members. J Prev Alz Dis 2015;2(2):128-135. Download PDF (242.35 Ko). K Kahle-...
probiodrug.de
Probiodrug | Events Archive
http://www.probiodrug.de/news-events/events-archive
Research & Development. News & Events. Subscribe for our latest News. You can meet the Probiodrug team at the following events:. 20 – 22: 7th annual CTAD. 19 – 20: Jefferies Global Healthcare Conference. 15 – 19: Society for Neuroscience 44th annual meeting. Washington DC, USA. 12 – 14: Alzheimer’s Fast Track. Alexandria, Virginia, USA. 10 – 11: East/West CEO Conference Boston Biotech Conference. San Francisco, USA. 12 – 16: JP Morgan 33rd Annual Healthcare Conference, San Francisco, USA. 27: Sofinnova J...
rad-md.org
RadMD: Radiology in Medical Development
http://www.rad-md.org/news.php
JAMA Article on Gadolinium Exposure and Parkinson s: A False Sense of Safety? Welk B, McArthur E, Marrow SA, et al. Association between Gadolinium contrast Exposure and the Risk of Parkinsonism. JAMA 2016;316:96-98. August 09, 2016. 1 Welk B, McArthur E, Marrow SA, et al. Association between Gadolinium contrast Exposure and the Risk of Parkinsonism. JAMA 2016;316:96-98. 2 https:/ www.lawsonresearch.ca/news/study-casts-doubt-clinical-significance-gadolinium-brain-deposits. 7 Kanda T, Osawa, M, Hiroshi O, ...